Skip to main content
. 2015 Aug 10;5:12891. doi: 10.1038/srep12891

Table 1. Familial cancer risks conferred by affected parents and siblings.

Cancer site Patients with negative family history 1 parent affected
1 parent (age limited) affected1
1 sibling affected
p-value for difference between RRsib and RRPar2
N3 RR4 95% CI5 N RR 95% CI N RR 95% CI
Upper aerodigestive tract 7236 136 1.51 (1.13–2.02) 113 1.57 (1.14–2.15) 56 1.73 (1.10–2.72) 0.72
Esophagus 2248 26 2.45 (1.55–3.90) 18 2.33 (1.34–4.05) 12 3.36 (1.70–6.62) 0.41
Stomach 4411 222 1.72 (1.47–2.02) 172 1.78 (1.49–2.13) 46 2.97 (2.11–4.18) 0.0090
Small intestine 1489 17 4.81 (2.99–7.75) 14 5.34 (3.16–9.01) 14 10.11 (5.98–17.09) 0.09
Colorectum 25187 2945 1.72 (1.64–1.80) 2100 1.80 (1.71–1.90) 905 2.00 (1.84–2.17) 0.0294
Liver 4625 130 1.61 (1.29–1.99) 101 1.78 (1.39–2.27) 30 2.07 (1.32–3.23) 0.56
Pancreas 5152 178 1.96 (1.66–2.33) 140 2.09 (1.73–2.54) 54 2.73 (2.01–3.71) 0.15
Lung 18111 1346 1.86 (1.74–1.99) 1108 1.92 (1.78–2.07) 712 2.50 (2.28–2.74) <.0001
Breast 56566 6102 1.73 (1.67–1.80) 4989 1.78 (1.70–1.85) 3493 1.84 (1.75–1.94) 0.24
Cervix 8074 128 1.57 (1.28–1.93) 122 1.59 (1.29–1.96) 54 2.03 (1.48–2.78) 0.21
Endometrium 9298 301 2.21 (1.88–2.61) 257 2.37 (1.98–2.83) 128 2.13 (1.66–2.73) 0.49
Ovary 8633 261 2.52 (2.20–2.88) 241 2.67 (2.32–3.07) 122 2.97 (2.44–3.61) 0.38
Prostate 37805 6622 2.10 (2.03–2.18) 4469 2.33 (2.24–2.43) 3390 2.59 (2.48–2.72) 0.0005
Testis 6652 32 3.90 (2.63–5.79) 32 3.96 (2.67–5.86) 82 6.94 (5.42–8.89) 0.0173
Kidney 7739 201 1.58 (1.34–1.87) 175 1.68 (1.40–2.01) 75 2.09 (1.59–2.75) 0.18
Urinary bladder 10944 513 1.76 (1.56–1.98) 370 1.84 (1.61–2.12) 172 1.90 (1.55–2.32) 0.81
Melanoma 22807 763 2.43 (2.23–2.66) 643 2.55 (2.32–2.81) 584 2.74 (2.48–3.03) 0.31
Skin, squamous cell 8369 426 2.07 (1.86–2.29) 189 2.16 (1.85–2.52) 104 2.25 (1.83–2.77) 0.75
Nervous system 19099 371 1.54 (1.35–1.75) 349 1.58 (1.38–1.80) 215 1.71 (1.44–2.03) 0.45
Thyroid gland 4791 90 5.13 (3.91–6.74) 87 5.61 (4.25–7.40) 48 5.43 (3.74–7.87) 0.86
Endocrine glands 7810 130 2.05 (1.61–2.62) 110 1.99 (1.53–2.59) 60 1.98 (1.38–2.83) 0.98
Non–Hodgkin lymphoma 11895 276 1.61 (1.41–1.84) 203 1.65 (1.41–1.93) 124 1.69 (1.38–2.06) 0.85
Hodgkin lymphoma 3931 19 2.57 (1.65–3.98) 18 2.59 (1.65–4.07) 40 9.60 (7.08–13.00) <.0001
Myeloma 3296 61 2.12 (1.64–2.74) 40 1.96 (1.43–2.68) 22 2.73 (1.79–4.18) 0.21
Leukemia 12149 277 1.86 (1.62–2.14) 216 1.88 (1.61–2.20) 105 2.17 (1.73–2.71) 0.31

1Individuals were only considered to have a positive family history if the parental cancer was diagnosed at age ≤ 78 years.

2Risk estimates for limited parental age were considered for comparison.

3N = Number of cases with a concordant cancer in the family.

4RR = Relative risk.

5CI = Confidence interval.